111, Inc. Announces ADS Ratio Change

Core Viewpoint - 111, Inc. plans to change the ratio of its American Depositary Shares (ADSs) from one ADS representing two Class A ordinary shares to one ADS representing twenty Class A ordinary shares, effectively a one-for-ten reverse ADS split [1][2]. Company Overview - 111, Inc. is a leading tech-enabled healthcare platform in China, focused on reshaping the healthcare value chain by digitally empowering both upstream and downstream sectors [1][4]. - The company provides consumers with improved access to pharmaceutical products and healthcare services through its online retail pharmacy, 1 Pharmacy, and its offline virtual pharmacy network [4]. - 111 also offers online healthcare services via its internet hospital, 1 Clinic, which includes online consultations, electronic prescriptions, and patient management services [4]. - The company operates the largest virtual pharmacy network in China, enabling offline pharmacies to enhance customer service through cloud-based solutions [4]. - Additionally, 111 provides an omni-channel drug commercialization platform that includes digital marketing, patient education, data analytics, and pricing monitoring for its strategic partners [4]. ADS Ratio Change Impact - The ratio change will not affect the underlying Class A ordinary shares, and no shares will be issued or cancelled as a result [2]. - The change is expected to take effect on January 24, 2025, and the ADS price is anticipated to increase proportionally, although no assurance can be given regarding the exact price post-change [2].